Company profile · federal money
Sygnamap Inc
Sygnamap Inc received $0 in federal awards in FY2025 (down 100% from FY2024).
- FY2025 federal obligations
- $0
- FY2024
- $400.0K
Data through 2026-09-30; source: USAspending.gov.
Gathering everything on record…
From public government records, which may contain errors. Check the official source before relying on a number. Not financial, legal or investment advice. Terms · About the data
SBIR & STTR awards
6 small-business research awards (1 Phase II) worth $1.73M, 2021–2024.
- Metabolite Reference Standards to Normalize Spatial Metabolomics Across Tissue Sections Department of Commerce · SBIR Phase II · $400.0K · 2024
- Metabolite Reference Standards to Normalize Spatial Metabolomics Across Tissue Sections Department of Commerce · SBIR Phase I · $100.0K · 2023
- Quantitative Normalization of Spatial Metabolomics for Molecular Signatures of Tissue Heterogeneity Department of Health and Human Services · SBIR Phase I · $356.5K · 2023
- SBIR Phase I:Computational platform to infer putative causative pathways of pathology using spatial omics data National Science Foundation · SBIR Phase I · $256.0K · 2022
- Precision Mass Spec Imaging Based Structure-Function Signatures of Diabetic Glomerulopathy Department of Health and Human Services · SBIR Phase I · $306.5K · 2021
All of its SBIR & STTR awards · SBA's SBIR.gov data